Prostate cancer is a type of cancer that affects men, and while there is no cure yet, being aware of the signs and symptoms is important. One of those symptoms is usually present during the colder times of the year.
Express reports that frequent urination may be a symptom of the disease. This is especially present during the colder times of the year, and in this case, peeing frequently may indicate that the disease has affected the tube responsible for carrying urine from the bladder to the penis.
As with any disease or condition, it is very important to note that symptoms tend to overlap with others, so this may not always mean prostate cancer but it could indicate something else. On a more positive note, it could simply indicate the biological process called cold weather diuresis, which is the body’s response to cold weather or cold environments. According to Doctor 4 U’s Dr. Diana Gall: “The biological response is to redirect blood to the core to create warmth, while the kidneys release extra fluid to stabilize the pressure.” Therefore this results in increasing the production of urine.
This urge to urinate frequently due to the cold weather may also be a sign of an enlarged prostate rather than prostate cancer as well.
Previously, Express reported that scientists have made a breakthrough when it comes to detecting the disease early on. The scientists believe that this method may change the way doctors can detect the disease. Although existing methods such as the Prostate-Specific Antigens are there to spot the disease, there have been some false positives as a portion of the men who have high levels of PSA do not have cancer after all.
In case there are men who do have cancer after being detected by the PSA, doctors are now posed with the challenge of determining whether the cancer is already aggressive or it is in its early stages and is least likely going to be fatal.
This new method was studied by researchers from the Queen Mary University in London. The lead researcher, Professor Yong-Jie Lu stated that testing for circulating tumor cells or CTC is more effective as well as non-invasive without any need for surgery. Their study was conducted in 98 pre-biopsy patients and 155 newly-diagnosed cancer patients. The results turned out to be accurate, including the predictions of later biopsies.
When used together, the two tests would yield results that were 90 percent accuracy and also indicated how aggressive the cancer cells would be.


Trump Signs Executive Order to Boost AI Research in Childhood Cancer
Canada Loses Measles-Free Status After Nearly 30 Years Amid Declining Vaccination Rates
U.S. Reveals 2026 Medicare Star Ratings: Aetna, UnitedHealth Lead in Quality Scores
Novo Nordisk Appoints Greg Miley as Global Head of Corporate Affairs Amid U.S. Pricing Pressure
FDA Pilot Program Eases Rules for Nicotine Pouch Makers
Trump Hints at Major Autism Announcement, Raises Questions on Tylenol Link
Pfizer Boosts Bid for Metsera Amid Intensifying Rivalry with Novo Nordisk in Obesity Drug Market
U.S. Backs Bayer in Supreme Court Battle Over Roundup Cancer Lawsuits
Eli Lilly’s Weight-Loss Pill Nears Fast-Track FDA Approval as Profits Surge on Global Demand
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment
Pfizer Secures $10 Billion Deal for Obesity Drug Developer Metsera, Outbids Novo Nordisk
U.S. Experts to Reassess Newborn Hepatitis B Vaccination Guidelines Amid Growing Debate
Trump Backs Review of U.S. Childhood Vaccine Schedule After Hepatitis B Policy Change
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment 



